Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Gastric Cancer Drugs Market Report by Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Route of Administration (Oral, Parenteral), End User (Hospitals, Clinics, and Others), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A6648
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Gastric Cancer Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Doxorubicin Hydrochloride
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sunitinib
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Docetaxel
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Mitomycin
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Fluorouracil
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Imatinib
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Trastuzumab
6.7.1 Market Trends
6.7.2 Market Forecast
7 Market Breakup by Route of Administration
7.1 Oral
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Parenteral
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Arog Pharamaceuticals Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Bristol-Myers Squibb Company
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Daiichi Sankyo Company Limited
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Ono Pharmaceutical Co. Ltd.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Sanofi S.A.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Taiho Pharmaceutical Co. Ltd. (Otsuka Pharmaceutical Co. Ltd.)
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report
List of Figures
Figure 1: Global: Gastric Cancer Drugs Market: Major Drivers and Challenges
Figure 2: Global: Gastric Cancer Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Gastric Cancer Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Gastric Cancer Drugs Market: Breakup by Type (in %), 2023
Figure 5: Global: Gastric Cancer Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Gastric Cancer Drugs Market: Breakup by End User (in %), 2023
Figure 7: Global: Gastric Cancer Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Gastric Cancer Drugs (Doxorubicin Hydrochloride) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Gastric Cancer Drugs (Doxorubicin Hydrochloride) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Gastric Cancer Drugs (Sunitinib) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Gastric Cancer Drugs (Sunitinib) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Gastric Cancer Drugs (Docetaxel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Gastric Cancer Drugs (Docetaxel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Gastric Cancer Drugs (Mitomycin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Gastric Cancer Drugs (Mitomycin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Gastric Cancer Drugs (Fluorouracil) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Gastric Cancer Drugs (Fluorouracil) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Gastric Cancer Drugs (Imatinib) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Gastric Cancer Drugs (Imatinib) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Gastric Cancer Drugs (Trastuzumab) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Gastric Cancer Drugs (Trastuzumab) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Gastric Cancer Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Gastric Cancer Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Gastric Cancer Drugs (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Gastric Cancer Drugs (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Gastric Cancer Drugs (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Gastric Cancer Drugs (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Gastric Cancer Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Gastric Cancer Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Gastric Cancer Drugs (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Gastric Cancer Drugs (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: North America: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: North America: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: United States: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: United States: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Canada: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Canada: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Asia-Pacific: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Asia-Pacific: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: China: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: China: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Japan: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Japan: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: India: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: India: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: South Korea: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: South Korea: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Australia: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Australia: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Indonesia: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Indonesia: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Others: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Others: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Europe: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Europe: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Germany: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Germany: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: France: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: France: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: United Kingdom: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: United Kingdom: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Italy: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Italy: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Spain: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Spain: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Russia: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Russia: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Others: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Others: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Latin America: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Latin America: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Brazil: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Brazil: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Mexico: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Mexico: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Others: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Others: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Middle East and Africa: Gastric Cancer Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Middle East and Africa: Gastric Cancer Drugs Market: Breakup by Country (in %), 2023
Figure 80: Middle East and Africa: Gastric Cancer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Global: Gastric Cancer Drugs Industry: Drivers, Restraints, and Opportunities
Figure 82: Global: Gastric Cancer Drugs Industry: Value Chain Analysis
Figure 83: Global: Gastric Cancer Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Gastric Cancer Drugs Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Gastric Cancer Drugs Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Gastric Cancer Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Gastric Cancer Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Gastric Cancer Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Gastric Cancer Drugs Market: Competitive Structure
Table 7: Global: Gastric Cancer Drugs Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More